A new SWL titanium stent (Zebra Stent): resistance to shockwave exposure

BACKGROUND AND PURPOSE: Recently, a new-concept lumen-less Teflon-coated double-J wire stent (Zebra stent) has been introduced to facilitate residual stone clearance, in particular after SWL. Its metal core expresses highly mismatched acoustic impedance. It was the aim of this study to exclude damage to the stent through shockwaves. Also, its Teflon coating should to some degree prevent encrustation, and stents removed from stone formers were examined for encrustation. MATERIALS AND METHODS: Series of 2000 shockwaves of an average and a maximum energy were applied to defined areas of Zebra stents in a waterbath on a Siemens Multiline Lithotriptor. Stents were then examined for core and sheath damage by digital photography, scanning electron microscopy, and microradiography. In addition, two Zebra stents and one conventional double-J stent from two stone formers were assessed in the same way for damage and encrustation. RESULTS: There was no damage whatsoever to either of the stents. Whereas there was considerable encrustation on the conventional double-J stent, there was none on the Zebra stents after 4 and 5 weeks in situ. CONCLUSIONS: Zebra stents resist shockwaves to a maximum number and energy sufficiently to be applied safely under SWL. Whether they resist encrustation to a higher degree in the short term than conventional stents remains to be established.     

Encrusted urinary stents: evaluation and endourologic management

Ureteral stents and nephrostomy tubes have been used extensively in urology. Attendant to their use are their associated morbidities, such as pain, infection, and encrustation. We review the literature on the subject of the encrusted stents and drainage catheters, discuss the risk factors for encrustation, and describe the endourologic evaluation and management of these encrusted and retained urinary drainage devices. A variety of factors contribute to the rate at which this process occurs, including the material of the stent or catheter, urine composition, and duration of use. The risk of stent encrustation is increased in patients with a history of urolithiasis and with progressively longer indwelling times. Novel stent designs incorporating antimicrobial eluting stents and stents with enzymes to degrade urinary oxalate have shown promise in vitro to minimize stent morbidity. Imaging plays a pivotal role in determining the appropriate surgical management of the encrusted and retained stent. In cases in which encrustation is minimal, extracorporeal shock wave lithotripsy has been used with high success rate. Calcifications along the ureteral component of the stent can be treated with retrograde ureteroscopy and laser lithotripsy while the percutaneous route is the preferred primary approach when stone size is greater than 2 cm and/or if there is associated significant encrustation on the proximal ureteral end of the stent. It is not unusual to need multiple sessions to successfully render the patient stent and stone free, depending on which modalities are used. A computerized tracking system for patients with indwelling ureteral stents has been advocated to reduce the number of "forgotten" stents. Finally, it is of paramount importance that the treating urologist communicates clearly to the patient the presence of any internal urologic stents, the temporary intent of their use, risks with prolonged indwelling times, and the need for appropriate follow-up to avoid complications of encrustation.     

Effect of uropathogens on in vitro encrustation of polyurethane double J ureteral stents

Polyurethane stents are used when there is an obstruction to the flow of urine. A majority of the patients with such stents are at the risk of urinary tract infection and salt encrustation. The present study is aimed at analyzing the in vitro encrustation of calcium oxalate and other salts in the presence of common uropathogens (E. coli and P. mirabilis) on films made from Tecoflex^®, a commercial grade polyurethane. In the absence of uropathogens, sodium ions and ammonia favor calcium adsorption whereas magnesium ions greatly depress it, resulting in increased hydrophillicity of the stent. With E. coli, Mg ions enhance the encrustation of calcium, whereas the other salts decrease its deposition. In case of P. mirabilis, irrespective of the type of salt, it enhances calcium encrustation except in the presence of sodium ions. Adhesion of uropathogens to the stent surface was higher in the presence of bovine serum albumin. Understanding the dynamics between various salts and microorganism in the urine, and urine–stent interface would aid in designing stents that are inert, resist encrustation and biofilm formation.     

Clinical features determining the fate of a long-term,indwelling, forgotten double J stents

We review our experiences with forgotten stents and investigate the potential factors determining the degree of encrustation. Our series consists of nine cases of forgotten stent that had remained indwelling for more than 1 year (mean 36.1 months). We describe and compare their various clinical parameters in terms of encrustation. In addition, we briefly summarize our management schemes. All patients showed few stent related irritative symptoms. Six cases showing minimal or no encrustation shared the common feature of urine hypotonicity. Cystoscopic pullout was possible in these cases. The remaining three cases showed moderate to severe encrustation around the stent which required multiple procedures. Pyuria was observed in all cases and two patients had a history of urolithiasis. Finally, all cases were rendered stent and stone free. The fate of forgotten stents was dependent on the amount of encrustation around the stent. In our study, lithogenic history and presence of pyuria were associated with moderate to severe encrustation. Interestingly, patients showing urine hypotonicity tended to have a minimal encrustation on their stents and the stents were easily removed. Therefore, in patients with an impaired renal concentrating ability and a poor medical condition, the duration of indwelling stents might be safely prolonged if the patient has no risk factor for encrustation. As patients with forgotten stents are less likely to complain of stent related symptoms, thorough education of patients is important to prevent stent related complications.     

Encrustation of urologic double pigtail catheters—an ex vivo optical coherence tomography (OCT) study

This study aims to evaluate whether optical coherence tomography (OCT) using both the surface and the endoluminal technique is feasible to investigate the locations and degree of encrustation process in clinically used ureteral stents. After removal from patients, 14 polyurethane JJ stents were investigated. A fresh JJ served as a control. The external surfaces were examined using an endoscopic surface OCT whereas the intraluminal surfaces were investigated by an endoluminal radial OCT device. The focus was on detection of encrustation or crystalline sedimentation. In 12 female and two male patients, the median indwelling time of the ureteral catheter was 100 days (range, 19–217). Using the endoluminal OCT, the size and grade of intraluminal encrustation could be expressed as a percentage relating to the open lumen of the reference stent. The maximum encrustation observed resulted in a remaining unrestricted lumen of 15–35 % compared to the reference. The luminal reduction caused by encrustation was significantly higher at the proximal end of the ureteral stent as compared to its distal part. The extraluminal OCT investigations facilitated the characterization of extraluminal encrustation. OCT techniques were feasible and facilitated the detection of encrustation of double pigtail catheters on both the extra and intra luminal surface. Quantitative expression of the degree of intraluminal encrustation could be achieved, with the most dense and thickened occurrence of intraluminal incrustation in the upper curl of the JJ stent.     

A model to quantify encrustation on ureteric stents, urethral catheters and polymers intended for urological use

OBJECTIVE: To validate an encrustation model and to quantify encrustation on currently used urological devices and polymers intended for urological use. Materials and methods An encrustation model was validated: (i) to measure the amount of calcium leaching from the glass model and from the polymer used; (ii) to determine whether the use of a single-source or pooled urine produced similar results; (iii) to determine in vitro encrustation; and (iv) to compare the results of in vivo implantation of the same materials into the bladders of rodents with the in vitro results. A test polymer (a ureteric stent, a urethral catheter or a biomaterial) and a control silicone polymer were housed separately but received human urine from the same reservoir and under the same conditions (pH 6.0 and 37 degrees C) for 5 days. The amount of calcium encrustation on each polymer was measured using atomic absorption spectroscopy. Each experiment was repeated at least four times and the results expressed as an encrustation index, defined as the ratio of encrustation of the test and reference polymers. RESULTS: The amount of calcium leaching from the glass model and polymers tested was insignificant. The use of a single-source or pooled urine gave the same results in the encrustation model. The in vitro results correlated with in vivo implantation of disks into the bladders of rats. Among the commonly used ureteric stents tested, the Cook C-Flex ureteric stents encrusted least. Hydrogel-coated ureteric stents encrusted more than uncoated stents. The Bard polytetrafluoroethylene short-term urethral catheter encrusted more than the Bard hydrogel-coated long-term catheter. A plasma-activated surface modification of a synthetic biomaterial with hyaluronic acid encrusted less than silicone, a long-term biomaterial widely regarded as the 'gold standard'. CONCLUSION: This validated encrustation model is the first to quantify encrustation on currently available ureteric stents and urethral catheters. A novel coating for a biomaterial was identified using the encrustation model, and which encrusted less than silicone.     

In vitro encrustation of a semi-permanent polymer-covered nitinol ureter stent: an artificial urine model

Purpose

To measure and compare the percentage of surface and luminal thickness of encrustation in Allium and conventional double J ureteric stents after exposure for 6 weeks to an accelerated encrustation model.

Material and Methods

An artificial urine solution was prepared and three stents were immersed into each of six containers allocated to each stent type, representing each week of encrustation. Slight agitation was accomplished by placing a magnetic stirrer at the bottom of each container. Images were obtained by examination under a stereomicroscope and analyzed with the aid of specialized image analysis software (Image J).

Results

By week 2, nearly 100 % of the stent surface was covered by a thin layer of encrustation, gradually increasing in thickness through weeks 3–6. On completion of 6 weeks of encrustation, the 10 mm length double J stent specimens did not show visible encrustation, while the 60 mm long Allium stents showed 100 % surface coverage. This was most evident in the mid-section of the stents compared to the ends, suggesting a correlation between stent length and encrustation formation. There was also no blockage of the lumen of either stents between weeks 1–6.

Conclusion

The designed accelerated encrustation model was successful and showed 80 % surface coverage after 6 weeks. In our study, there appears to be a slightly reduced level of surface encrustation to that of earlier reports. A correlation between stent length and geometry was suggested. This model may be used to compare encrustation for a variety of polymeric stent materials.     

Heparin coating on ureteral Double J stents prevents encrustations: an in vivo case study

PURPOSE: To evaluate the ability of heparin coating to inhibit Double J stent encrustation and compare it with the classic polyurethane Double J stent. PATIENTS AND METHODS: The study involved five patients with bilateral obstructions, who required bilateral ureteral Double J stent placement. Every patient received a heparin-coated Double J stent and a traditional polyurethane Double J stent for 1 month. After removal, the stents were analyzed using field emission scanning electron microscopy (FESEM), energy dispersive spectroscopy (EDS), and micro-infrared spectrophotometry (Micro-IR). These same techniques were used to analyze the heparin-coated and uncoated stents before insertion. The thickness, extension, and composition of encrustation of the coated and uncoated stents were compared. Moreover, two heparin-coated stents were analyzed with the same techniques after they had been in place for 10 and 12 months. RESULTS: FESEM analysis showed that the difference in encrustation thickness and extension between the two groups was significant. EDS and Micro-IR confirmed that in the heparinized stents the encrustations were not as uniform and compact as those in the uncoated stents. The stents that were left in place long-term were free of encrustations and had no changes in the heparin layer. CONCLUSIONS: Heparin coating reduces stent encrustation. Moreover, as no changes were seen in the heparin layer, we concluded that covalent heparin bonding enhances its adhesion to the polyurethane surface and ensures its stability for long periods. The heparin-coated stent appears to be a useful tool for long-term urinary drainage.     

Triclosan loaded ureteral stents decrease proteus mirabilis 296 infection in a rabbit urinary tract infection model

PURPOSE: Infection and encrustation remain major limitations of ureteral stent use and to our knowledge no device has completely overcome these obstacles to date. Triclosan is a biocide currently used in a plethora of consumer and medical products that has recently been loaded into a ureteral stent. Using a rabbit model of UTI we examined the effects of triclosan impregnated stent segments on the growth and survival of Proteus mirabilis, a uropathogen commonly associated with device related UTI and encrustation. MATERIALS AND METHODS: A total of 48 male New Zealand White rabbits were instilled transurethrally with 1 x 10(6) P. mirabilis 296. A stent curl from a triclosan eluting, Percuflex Plus or Optima ureteral stent was placed intravesically. Urine was cultured on days 1, 3 and 7. On day 7 the stents were assessed for encrustation and viable organisms, while the bladders were scored for the degree of inflammation. RESULTS: Throughout the study urine isolated from the triclosan group contained significantly fewer viable organisms than controls with 7 of 13 animals completely clearing the infection by day 7. Similarly 9 of 13 triclosan eluting stents showed no viable organisms upon recovery and the remaining 4 showed significantly fewer organisms than controls. Urine and stents in all controls were positive for P. mirabilis at all time points. Although there was no significant difference in encrustation among the groups, bladders harvested from the triclosan group demonstrated significantly less inflammation. CONCLUSIONS: Triclosan eluting stents greatly decreased P. mirabilis growth and survival in a rabbit UTI model compared to controls. These stents may prove useful for decreasing device related P. mirabilis UTIs.     

The development of synthetic polymers that resist encrustation on exposure to urine.

The consequences of long-term exposure of synthetic materials to urine have prevented the development of alloplastic replacement of diseased or damaged parts of the urinary tract. Similarly, urethral and ureteric catheters require regular replacement if the complications of encrustation and blockage are to be avoided. The mechanism of encrustation is not understood completely and thus it is unclear why certain materials appear better able to resist encrustation. This study has involved the development of a new encrustation model to provide a reproducible and quantitative assessment of the susceptibility of polymers to encrustation. This model will allow beneficial characteristics of co-polymer design to be recognised, with the aim of finding new materials that are tolerant of exposure to urine. Results of co-polymers examined show that the incorporation of fluorine-containing components confers significant resistance to the formation of encrustation. It is suggested that the physico-chemical properties of polymer surfaces may be important determinants of resistance to encrustation.     

Advances in ureteral stent design

BACKGROUND AND PURPOSE: Ureteral stents are widely used in patients with urologic disorders. This review critically evaluates the recent literature, providing an update on advances in the development and design of stents. METHODS: A thorough MEDLINE and PubMed literature search on ureteral stents was performed, and all pertinent articles were reviewed in detail. This review was formulated on the basis of these articles, encompassing both basic science and clinical aspects of advances in ureteral stent design. RESULTS: The advances in development and design have been directed primarily toward decreasing stent-related morbidity such as discomfort, bladder irritability, infection, encrustation, and the need for an additional cystoscopic procedure to remove the stent. In recent years, there have been many significant advances in the design of ureteral stents, including tapered distal ends, and construction, such as magnetic, biodegradable, and tissue-engineered materials. CONCLUSIONS: There are many different bulk materials and coatings available for the manufacturing of ureteral stents, many of which are new. However, the ideal biomaterial has yet to be discovered. With ongoing research in this area, further advances in ureteral stent design will continue to improve outcomes for patients who require stents. Future advances are likely to include drug-coated stents, drug-eluting stents, and localized stenting techniques such as endoluminal gel paving.     

Stent encrustation in feline and human artificial urine: does the low molecular weight composition account for the difference?

Anecdotal evidence suggests that the rate of encrustation on JJ stents placed in domesticated cats appears to be decreased as compared to humans. Our study tests the hypothesis that this may be due to specific differences in the chemical composition of human and feline urine. Artificial human and feline urine solutions were used in an in vitro encrustation model where an 80 % stent encrustation could be expected after 7 weeks of incubation. Scanning electron microscopy (SEM) was used to analyse crystal morphology. Energy dispersive X-ray spectrometry (EDS) was used to assess composition weight. The percentage of surface coverage of encrustation on the respective stents was quantified using image J Java plug-in software. No significant difference was observed between both solutions with regard to quality and quantity of stent encrustation. Crystals were formed in both solutions as a mixture of Ca-dihydrate and Ca-monohydrate. The study shows that there is no significant difference in the rate of encrustations on JJ stents incubated in artificial feline or human urine. This suggests that a possible difference in stent encrustation between cats and humans is due to factors other than the inorganic biochemical composition of the urines alone. Keeping in mind a true species difference, analysis of urinary macromolecules and proteins will be the logical next step.     

介入治疗中支架材料的研究进展

介入治疗中经常需要植入支架。但是，再狭窄、感染、凝血、硬壳或者结石的形成仍然是支架植入术后容易发生的问题。本文综述支架材料领域的最新进展，重点涉及支架设计、支架涂层及可降解支架。     

Characteristics and usage of different ureteral stent catheters.

Presuming that complications associated with ureteral stenting vary in type and occurrence depending on the material and cross-section of the stent, six types of stents immersed in 48 different preparations of artificial urine for 1 month to observe surface changes with a scanning electron microscope. As a result, there was less encrustation on the silicone material compared with other material types, probably due to the smoothness of the surface. This may be related with higher frequency of spontaneous removal or migration to the bladder of this catheter type. Because silicone catheters have softer and thicker walls with a narrow lumen, they may be appropriate for long-term stenting, but not for urinary drainage. In alkaline bacteriuria, struvite encrustation was observed on all stents. This reaction was especially intense with Towers peripheral stents, which had most irregular and uneven surfaces. In aseptic alkaline urine, calcium phosphate crystals partly covered with proteinaceous debris were noted on catheter surfaces. Although in some patients encrustation of uric acid occurred in the bladder portion of the stents, there was no uric acid encrustation in this experimental study.     

Technology insight: Novel ureteral stent materials and designs

Ureteral stents are an important tool for aiding upper urinary tract drainage, but can cause significant patient morbidity. Common problems include stent-induced pain, hematuria, dysuria, infection, and encrustation. From a urologist's perspective, stents must be easy to maneuver in the urinary tract, radiopaque, and affordable. Since the development of the modern day stent in 1978, stents have evolved to include softer biomaterials that are more resistant to encrustation and infection. An ideal biomaterial is one that is not affected by its environment and does not elicit reactive changes in surrounding tissues. To date, the ideal biomaterial or stent does not exist. This review discusses developments that address the issues of infection, biofilm formation, encrustation, and patient comfort. Stent materials including polyurethane, silicone, biodegradable substances and new combination polymers are reviewed, in addition to novel stent coatings such as heparin, hydrogel, and silver nitrate. Ureteral stent technologies currently lag behind vascular stents, particularly drug-eluting stents, but new developments will continue to improve these essential urological tools.     

Pentosanpolysulfate coating of silicone reduces encrustation

BACKGROUND AND PURPOSE: A significant problem associated with catheterization in the urinary tract is the encrustation of the catheter materials. One approach to reducing encrustation is to alter the surface properties of the catheters. We evaluated the effectiveness of coating with pentosanpolysulfate (PPS), a semisynthetic polysaccharide similar to heparin, in reducing encrustation and the foreign-body inflammatory response to silicone stents in the bladders of male New Zealand White rabbits. MATERIALS AND METHODS: Sixteen rabbits were divided into three groups to receive placement in their bladders of uncoated (N = 7), PPS-coated (N = 7), or sham matrix-processed silicone rings (N = 2) via open cystotomy. After 50 days of maintenance on normal food and water, all rabbits were sacrificed, and the air-dried, unfixed silicone ring surfaces were examined by scanning electron microscopy. Bladders and remaining silicone rings were removed and preserved separately. Silicone rings, cleaned of all encrustation, were stained with toluidene blue to determine the presence or absence of PPS coating on the surface. RESULTS: Histologic examination revealed normal tissue in bladder sections exposed to coated silicone rings and an inflammatory response in sections from bladders having uncoated silicone rings. Coating with PPS was associated with an eightfold reduction in the amount of encrustation of silicone and a marked reduction in the inflammatory response of the bladder wall to the foreign body. CONCLUSIONS: A PPS coating may be useful in reducing the encrustation of long-term indwelling silicone stents or catheters in the human urinary tract.     

Minimizing symptoms in patients with ureteric stents

PURPOSE OF REVIEW: The current approaches for minimizing symptoms in patients with ureteric stents were reviewed utilizing a literature search on Pubmed using the keywords stent, symptom, and ureter. RECENT FINDINGS: Ureteral stents are widely used in urological procedures for maintaining upper urinary tract drainage to relieve obstruction, pain, or infection. Indwelling stents, however, are associated with significant morbidity such as infection, encrustation, hematuria, and bothersome symptoms. Minimizing these issues has become paramount in the design of new ureteral stents. This article will review current and novel ways to minimize stent-related morbidity. SUMMARY: Currently, there is no ideal stent that relieves obstruction, is resistant to infection and encrustation, and is comfortable for patients. Advances in biomaterials and design will result in a more biocompatible stent that also has patient comfort in mind.     

Advances in ureteral stents

Ureteral stents are commonly used in urology. Every urologist is familiar with the problems that are associated with stents including infection, encrustation, and bothersome symptoms. These problems limit and affect the use of ureteral stents which are necessary, even in light of the problems they can cause. New designs such as a helically cut ureteral stent which is designed to stretch and conform to the ureter is designed to improve comfort. Drug-eluting designs with an antimicrobial (triclosan) are designed to reduce bacterial adherence to ureteral stents. Chlorhexidine, an antiseptic, has been incorporated into a stent and held in place by a slow release varnish to prevent biofilm formation. Combinations of antibiotics coated directly on the stent and administered systemically have been shown to reduce stent colonization both in vitro and in vivo. Gel-based ureteral stents were also showed to reduce bacterial infection and colonization. Bioabsorbable materials have also been designed to reduce infection, symptoms and prevent the forgotten stent syndrome. Newer designs including stents based on guidewire technology, gels, and a combination of self-expanding wire stents with polymer films are reviewed. There is hope on the horizon that new stents will be able to effectively tackle problems that are often seen with ureteral stents.     

Endo-urological techniques in the management of stent complications in the renal transplant patient

Complications following renal allograft transplantation have been well documented and, despite improvements in technique, continue to cause significant morbidity and mortality. The placement of indwelling ureteric stents is becoming more common both during primary neo-ureterocystostomy and in the management of subsequent ureteric complications. We present two cases of stent encrustation and urolithiasis treated by a combined percutaneous and flexible ureterorenoscopic approach. These cases illustrate the problems of stents in renal transplant patients and offer endo-urological solutions. It is imperative that stents are correctly placed in these patients and that appropriate plans are made for their removal or exchange.     

Comparison of urinary stone and stent encrustation: biochemical analysis

PURPOSE: To compare biochemical analysis of stent encrustation with that of urinary stones from the same patient. PATIENTS AND METHODS: Any patient presenting from February to December 2000 with a symptomatic ureteral or renal calculus that necessitated stenting and delayed calculus retrieval was enrolled in the study. The stent and stone were sent to the same laboratory for qualitative and semiquantitative chemical analysis. A total of 50 stents and matched calculi were available for comparison; four stents were excluded because they had insufficient encrustation for analysis. RESULTS: Two patients had open ureterolithotomy; the remainder were treated by endoscopic or percutaneous means. Every stone containing calcium oxalate had a stent that was positive for calcium oxalate. Four uric acid stones were available for comparison, and three of the four matched stents tested positive for uric acid. CONCLUSION: Biochemical analysis of urinary stent encrustation is a good predictor of urinary stone composition, especially for calcium oxalate-containing stones. Uric acid stent encrustation is likely to occur in patients with uric acid stones.